Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects
The Journal of immunology (1950), 2015-10, Vol.195 (7), p.3020-3025 [Peer Reviewed Journal]Copyright © 2015 by The American Association of Immunologists, Inc. ;ISSN: 0022-1767 ;ISSN: 1550-6606 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.1402869 ;PMID: 26290603
Full text available